Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Unigene awarded U.S. patent for oral calcitonin product

Aug. 4, 1999

GelTex seeks FDA approval of Cholestagel

Aug. 3, 1999

Novel MTP inhibitors in early development at Japan Tobacco

Aug. 3, 1999

MCH binding receptor identified

Aug. 3, 1999

Brazilian trial of Biotech Holdings' diabetes drug completed

Aug. 2, 1999

A review of SSRI-induced female sexual dysfunction and treatment strategies

Aug. 2, 1999

FDA approves Antagon for LH inhibition in women undergoing fertility treatment

July 30, 1999

Further preclinical testing of NTE-122 supports potential in hyperlipidemia

July 30, 1999

Bayer prepares selective beta3-adrenergic agents for obesity, diabetes

July 30, 1999

Millennium obtains patent coverage for novel weight-regulating compounds

July 29, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...